180 related articles for article (PubMed ID: 36107723)
21. Immune response and locoregional treatments for peritoneal carcinomatosis.
Fiorentini C; Sarti D; Guadagni S; Fiorentini G
Int Rev Cell Mol Biol; 2022; 371():97-116. PubMed ID: 35965002
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
G Chir; 2011 Apr; 32(4):211-33. PubMed ID: 21554854
[TBL] [Abstract][Full Text] [Related]
23. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies.
Li Y; Zhou YF; Liang H; Wang HQ; Hao JH; Zhu ZG; Wan DS; Qin LX; Cui SZ; Ji JF; Xu HM; Wei SZ; Xu HB; Suo T; Yang SJ; Xie CH; Yang XJ; Yang GL
World J Gastroenterol; 2016 Aug; 22(30):6906-16. PubMed ID: 27570426
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.
Lemoine L; Sugarbaker P; Van der Speeten K
World J Gastroenterol; 2016 Sep; 22(34):7692-707. PubMed ID: 27678351
[TBL] [Abstract][Full Text] [Related]
25. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part I: Introduction and Indications.
Dunn D
AORN J; 2019 Nov; 110(5):479-499. PubMed ID: 31660604
[TBL] [Abstract][Full Text] [Related]
27. Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.
Emoto S; Sunami E; Yamaguchi H; Ishihara S; Kitayama J; Watanabe T
Surg Today; 2014 Dec; 44(12):2209-20. PubMed ID: 24482110
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
29. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis.
Harada K; Yamashita K; Iwatsuki M; Baba H; Ajani JA
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):43-49. PubMed ID: 35184625
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal immunotherapy of peritoneal carcinomatosis.
Freedman RS; Lenzi R; Kudelka AP; Lawrence DD; Rosenblum M; Platsoucas CD
Cytokines Cell Mol Ther; 1998 Jun; 4(2):121-40. PubMed ID: 9681251
[TBL] [Abstract][Full Text] [Related]
32. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
[TBL] [Abstract][Full Text] [Related]
33. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
34. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
[TBL] [Abstract][Full Text] [Related]
35. Current treatment options for colon cancer peritoneal carcinomatosis.
Aoyagi T; Terracina KP; Raza A; Takabe K
World J Gastroenterol; 2014 Sep; 20(35):12493-500. PubMed ID: 25253949
[TBL] [Abstract][Full Text] [Related]
36. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.
Thadi A; Khalili M; Morano WF; Richard SD; Katz SC; Bowne WB
Vaccines (Basel); 2018 Aug; 6(3):. PubMed ID: 30103457
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.
Iversen LH; Rasmussen PC; Hagemann-Madsen R; Laurberg S
Colorectal Dis; 2013 Jul; 15(7):e365-72. PubMed ID: 23458368
[TBL] [Abstract][Full Text] [Related]
38. Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis.
Pesce S; Belgrano V; Greppi M; Carlomagno S; Squillario M; Barla A; Della Chiesa M; Di Domenico S; Mavilio D; Moretta L; Candiani S; Sivori S; De Cian F; Marcenaro E
Front Immunol; 2019; 10():1963. PubMed ID: 31497016
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.
Mahmoud AM; Ismail YM; Hussien A; Debaky Y; Ahmed IS; Mikhael HSW; Moneer M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):143-150. PubMed ID: 30472198
[TBL] [Abstract][Full Text] [Related]
40. Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Behrenbruch C; Hollande F; Thomson B; Michael M; Warrier SK; Lynch C; Heriot A
ANZ J Surg; 2017 Sep; 87(9):665-670. PubMed ID: 28664645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
